Kymera Therapeutics, Inc. (KYMR)
NASDAQ: KYMR · Real-Time Price · USD
84.58
-0.46 (-0.54%)
Mar 10, 2026, 4:00 PM EDT - Market closed
Kymera Therapeutics Market Cap
Kymera Therapeutics has a market cap or net worth of $6.91 billion as of March 10, 2026. Its market cap has increased by 201.96% in one year.
Market Cap
6.91B
Enterprise Value
5.37B
1-Year Change
201.96%
Ranking
Category
Stock Price
$84.58
Market Cap Chart
Since the IPO on August 21, 2020, Kymera Therapeutics's market cap has increased from $834.48M to $6.91B, an increase of 727.50%. That is a compound annual growth rate of 46.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 10, 2026 | 6.91B | 10.93% |
| Dec 31, 2025 | 6.22B | 138.91% |
| Dec 31, 2024 | 2.61B | 84.43% |
| Dec 29, 2023 | 1.41B | 3.16% |
| Dec 30, 2022 | 1.37B | -57.98% |
| Dec 31, 2021 | 3.26B | 18.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Aug 21, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Arrowhead Pharmaceuticals | 8.50B |
| Axsome Therapeutics | 8.41B |
| Nuvalent | 8.04B |
| Halozyme Therapeutics | 8.04B |
| Cytokinetics | 7.69B |
| Krystal Biotech | 7.56B |
| Belite Bio | 7.05B |
| Arcellx | 6.70B |